BRIEF published on 11/10/2025 at 18:10, 10 months 1 day ago Ascend's Innovation Enhances AAV Production Efficiency Gene Therapy Biotechnology Innovation Ascend Advanced Therapies AAV Production Manufacturing Enhancers
BRIEF published on 11/10/2025 at 18:10, 10 months 1 day ago L'innovation d'Ascend améliore l'efficacité de la production d'AAV Thérapie Génique Innovation En Biotechnologie Ascend Advanced Therapies Production AAV Améliorants De Fabrication
PRESS RELEASE published on 11/10/2025 at 18:05, 10 months 1 day ago Ascend Unveils Proprietary Enhancers That Significantly Improve AAV Yields Without Compromising Quality Ascend Advanced Therapies unveils proprietary enhancers demonstrating significant improvements in AAV yields and quality attributes for gene therapy programs Ascend Advanced Therapies Proprietary Enhancers AAV Yields Gene Therapy Programs Quality Attributes
BRIEF published on 10/08/2025 at 15:10, 11 months 3 days ago Ascend Advanced Therapies Successfully Defends EpyQ® Patent at EPO Intellectual Property Gene Therapy European Patent Office Ascend Advanced Therapies EpyQ® AAV Plasmid
BRIEF published on 10/08/2025 at 15:10, 11 months 3 days ago Ascend Advanced Therapies défend avec succès le brevet EpyQ® auprès de l'OEB Propriété Intellectuelle Thérapie Génique Office Européen Des Brevets Thérapies Avancées Ascend Plasmide AAV EpyQ®
PRESS RELEASE published on 10/08/2025 at 15:05, 11 months 3 days ago European Patent on Ascend Advanced Therapies' EpyQ® AAV Plasmid Technology Successfully Defended at the EPO Ascend Advanced Therapies successfully defends European patent EP3722434 for EpyQ® AAV plasmid technology at the EPO, reinforcing its position in gene therapy Gene Therapy European Patent Ascend Advanced Therapies EpyQ® AAV Plasmid Technology
Published on 09/12/2026 at 02:35, 10 hours 55 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 30 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 25 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 5 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 30 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 15 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 20 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 45 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 15 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
